{
    "question_id": "q4",
    "context": [
        {
            "id": 0,
            "source": "中国年龄相关性黄斑变性临床诊疗指南（2023年）",
            "content": "Corresponding author: Xu Xun, Department of Ophthalmology, Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine, National Clinical Research Center for Eye Diseases, Shanghai Key Laboratory of Ocular Fundus Diseases, Shanghai Engineering Center for Visual Science and Photomedicine, Shanghai Engineering Center for Precise Diagnosis and Treatment of Eye Diseases, Shanghai 200080, China, Email: drxuxun@tom.com\n\n【Abstract】 Age‑related macular degeneration (AMD) is the main cause of low vision and even blindness in the elderly. With the aging of our population, the number of AMD patients will continue to rise. In the past decade, the rapid development of ocular fundus imaging technology has provided a new perspective and approach for the classification, diagnosis and follow‑up of AMD. The advent of new drugs has provided more diverse intervention and treatment methods for AMD, especially for neovascular AMD, and the emphasis on accurate and individualized treatment has put forward higher requirements for retinal specialists. Therefore, based on the latest evidence‑based medical information, combined with the international guidelines and the current situation of China′s social and economic development, experts from the Chinese Vitreo‑Retinal Society of Chinese Medical Association, the Fundus Disease Group of Chinese Ophthalmologist Association, and the\n\nNational Clinical Research Center for Eye Diseases gave recommendations around eight clinical problems and formed China′s guidelines for the clinical diagnosis and treatment of AMD. With the implementation of these guidelines, we can standardize the diagnosis, treatment, prevention and follow‑up of AMD in China. (This article was published ahead of print on the official website of Chinese Journal of Ophthalmology on April 6, 2023)\n\n【Key words】 Macular degeneration; Practice guidelines as topic; Evidence‑based medicine\n\nPractice guideline registration: Practice Guideline Registration for Transparency, IPGRD‑2021CN111\n\n年 龄 相 关 性 黄 斑 变 性（age‑related maculardegeneration，AMD）是老年人群低视力乃至失明的主要原因［1］ ，2040年全球AMD患者数量预计将达到 2.88 亿例［2‑3］ 。我国 70 岁以上人群 AMD 的患病率为 $2 0 . 2 \\% ^ { [ 3 ] }$ ，随着我国人口老龄化的加剧，AMD的患者数量也在持续上升。\n\n2013 年国际 Beckmann AMD 分类研究小组根据临床表现，将 分为无明显年龄性改变、正常年 龄 性 改 变 、早 期 AMD、中 期 AMD 和 进 展 期$\\mathrm { A M D } ^ { [ 4 ] }$ 。 年 龄 相 关 性 眼 病 研 究（Age‑related Eye， ）小组的 分期标准与Beckmann分期类似［5］ 。进展期AMD又分为地图样萎缩（geographic atrophy，GA）和新生血管性 AMD，新生血管性AMD也称为渗出性或湿性AMD，占AMD 的 $1 0 \\% { \\sim } 2 0 \\% ^ { [ 1 ] }$ 。随着相干光层析成像术（optical coherence tomography，OCT）的应用和 AMD研究深入，国际AMD命名共识研究组于2020年更新了新生血管性 AMD 黄斑区新生血管（macularneovascularization，MNV）的分型，根据 OCT 图像中MNV的起源和位置，将其分为1、2和3型［6］。"
        },
        {
            "id": 1,
            "source": "眼底自发荧光在年龄相关性黄斑变性中的应用指南2023 ",
            "content": "关键词：眼底自发荧光；年龄相关性黄斑变性；临床应用\n\nDOI:10.3980/j.issn.1672-5123.2023.8.01\n\nGuidelines for the application of the fundus autofluorescence in age - related macular degeneration (2023)\n\nYi Shao $^{1}$ , Wei Chi $^{2}$ , Yan - Tao Wei $^{2}$ , Expert Workgroup of Guidelines for the Application of the Fundus Autofluorescence in Age - related Macular Degeneration (2023), Ophthalmic Imaging and Intelligent Medicine Branch of China Medical Education Association, Ophthalmology Branch of World Association of Translational Medicine, Chinese Ophthalmic Imaging Study Groups\n\nFoundation items: National Natural Science Foundation of China (No.82160195); Jiangxi Double-Thousand Plan High-Level Talent\n\nProject of Science and Technology Innovation (No. jxsq2023201036); Key R & D Program of Jiangxi Province (No. 20181BBG70004, 20203BBG73059); Outstanding Youth Fund Project of Jiangxi Province (No.20192BCBL23020)\n\n$^{1}$ Department of Ophthalmology, the First Affiliated Hospital of Nanchang University, Nanchang 330006, Jiangxi Province, China;  $^{2}$ Zhongshan Ophthalmic Center, Sun Yat - Sen University, Guangzhou 510060, Guangdong Province, China\n\nCorrespondence to: Yi Shao. Department of Ophthalmology, the First Affiliated Hospital of Nanchang University, Nanchang 330006, Jiangxi Province, China. freebee99@163.com; Wei Chi. Zhongshan Ophthalmic Center, Sun Yat-Sen University, Guangzhou 510060, Guangdong Province, China. chiwei@mail.sysu.edu.cn; Yan-Tao Wei. Zhongshan Ophthalmic Center, Sun Yat-Sen University, Guangzhou 510060, Guangdong Province, China. weiyantao75 @ 126.com\n\nInternational Practice Guidelines Registration: http://www.guidelines-registry.cn/, IPGRP-2022CN582\n\nReceived:2022-09-05 Accepted:2023-07-11\n\nAbstract\n\n- Fundus autofluorescence (FAF) imaging is based on the fluorescence excited by the endogenous fluorophores in the retinal pigment epithelium and choroid, mainly referring to lipofuscin (LF) and melanin. The non-invasive examination method can imply the function of retinal pigment epithelium by observing the spatial distribution of LF or melanin. This technique has unique advantages in the diagnosis and differentiation of age-related macular degeneration (ARMD). This guideline is to standardize and interpret the application of FAF in different stages and classifications of ARMD.\n\n- KEYWORDS: fundus autofluorescence; age - related macular degeneration; clinical application\n\nCitation: Shao Y, Chi W, Wei YT, et al. Guidelines for the application of the fundus autofluorescence in age-related macular degeneration (2023). Guoji Yanke Zazhi (Int Eye Sci) 2023; 23(8):1235-1241"
        },
        {
            "id": 2,
            "source": "中国黄斑病变低视力患者康复训练的专家共识",
            "content": "【Abstract】 Maculopathy caused by various fundus diseases in the late stage is a common cause of low vision. Medical technology is difficult to reverse the loss of macular function currently, so interventions that help improve the visual system, utilize residual visual function, and improve quality of life deserve attention. Damage to the fovea of the macula does not mean that the entire retinal function is impaired. There may be one or more retinal regions adjacent to the fovea that can serve as a fixation center. It is possible to form stable paracentral fixation, complete functional remodeling of the visual system, and effectively utilize residual visual function by taking appropriate training on these potential paracentral fixation points for most patients. In 2021, a clinical guideline has been published for low vision rehabilitation in China. In order to strengthen the precise management of diseases and develop a standard operating procedure for visual training specifically for patients with low vision due to macular disease, the National Clinical Research Center for Eye Diseases initiated and organized relevant domestic experts, utilizing the latest research experience at home and abroad, and through repeated discussions, this consensus (International Practice Guideline Registration Number: PREPARE2023CN199) was formed as a reference for ophthalmologists, optometrists and rehabilitation physicians in their clinical research and practice.\n\n【Key words】 Maculopathy;    Low vision;    Preferred retinal locus;    Target retinal locus;Rehabilitation training;    Expert consensus\n\nFund program: National Key R&D Program of China (2016YFC0904800, 2019YFC0840607); National Science and Technology Major Project of China (2017ZX09304010); Shanghai Key Clinical Specialty; Medical Guidance Program of Shanghai Municipal Commission of Science and Technology (19411961800)"
        }
    ],
    "query_top_k": 10,
    "rerank_top_n": 3,
    "query": "What is the treatment for age-related macular degeneration?",
    "index_name": "md-medical-guide-faiss-chunks",
    "rerank_model": "bm25",
    "embed_model": "openai:text-embedding-3-small"
}